Related Experiment Videos
[Anemia in rheumatoid arthritis]
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|June 1, 1980
Summary
Anemia in rheumatoid arthritis stems from complex factors, notably iron dysregulation. Lowered vitamin B12 levels are present in some patients, potentially linked to long-term therapies.
Area of Science:
- Rheumatology
- Hematology
- Internal Medicine
Context:
- Rheumatoid arthritis (RA) frequently presents with anemia, complicating patient management.
- The pathogenesis of anemia in RA involves iron metabolism disturbances and potential vitamin deficiencies.
Purpose:
- To investigate the origins and clinical significance of anemia in rheumatoid arthritis patients.
- To assess the correlation between anemia, hypoferremia, and disease activity/progression in RA.
- To determine the prevalence of decreased vitamin B12 levels and their relationship to RA course.
Summary:
- Anemia in RA is multifactorial, with increased iron in the reticuloendothelial system (RES) and reduced iron utilization being key factors.
- Anemia and hypoferremia in RA patients did not correlate with disease activity but were associated with joint involvement and disease progression, indicating unfavorable prognostic value.
- Decreased vitamin B12 levels were observed in 11.6% of patients, without a significant link to disease course, though impaired absorption due to long-term therapy is considered.
Impact:
- Highlights anemia and hypoferremia as potential prognostic markers in rheumatoid arthritis.
- Suggests the need to monitor iron status and vitamin B12 levels in RA patients.
- Informs potential therapeutic strategies targeting anemia in RA, considering iron metabolism and vitamin B12 absorption.